These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11279802)

  • 1. Radioimmunotherapy of solid tumors: from fairytale to reality.
    Adams GP; Weiner LM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
    [No Abstract]   [Full Text] [Related]  

  • 2. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
    Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
    Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunodiagnosis and radioimmunotherapy, 1982.
    Sfakianakis GN; DeLand FH
    J Nucl Med; 1982 Sep; 23(9):840-50. PubMed ID: 6180154
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapy.
    Ullén A; Ahlström KR; Heitala S; Nilsson B; Arlestig L; Stigbrand T
    Acta Oncol; 1996; 35(3):281-5. PubMed ID: 8679257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multivalent recombinant antibody fragment specific for carcinoembryonic antigen.
    Perez L; Ayala M; Pimentel G; Bell H; Canaán-Haden L; Bequet M; González LJ; Miranda M; Ravelo R; Roque L; Acevedo B; Oliva JP; Gavilondo JV
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):39-48. PubMed ID: 16101587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies.
    Sharkey RM; Juweid M; Shevitz J; Behr T; Dunn R; Swayne LC; Wong GY; Blumenthal RD; Griffiths GL; Siegel JA
    Cancer Res; 1995 Dec; 55(23 Suppl):5935s-5945s. PubMed ID: 7493374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
    Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
    Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
    Stein R; Juweid M; Mattes MJ; Goldenberg DM
    Cancer Biother Radiopharm; 1999 Feb; 14(1):37-47. PubMed ID: 10850286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor localization using radiolabeled monoclonal antibodies. An overview.
    Zalcberg JR
    Am J Clin Oncol; 1985 Dec; 8(6):481-9. PubMed ID: 3909809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.
    Kaulen H; Seemann G; Bosslet K; Schwaeble W; Dippold W
    Year Immunol; 1993; 7():106-9. PubMed ID: 8372499
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor pretargeting for radioimmunodetection and radioimmunotherapy.
    Zhu H; Jain RK; Baxter LT
    J Nucl Med; 1998 Jan; 39(1):65-76. PubMed ID: 9443740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential and limitations of radioimmunodetection and radioimmunotherapy with monoclonal antibodies.
    Zhu H; Baxter LT; Jain RK
    J Nucl Med; 1997 May; 38(5):731-41. PubMed ID: 9170438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunodetection using 131I-labeled anti-carcinoembryonic antigen antibodies for human malignant tumors].
    Itoh K; Hata Y; Nishi S; Kondo M; Furudate M; Irie G
    Kaku Igaku; 1985 Jun; 22(6):901-5. PubMed ID: 4057687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioimmunolocalization is a new aid used in the diagnosis of tumors].
    Lakartidningen; 1988 Nov; 85(46):3969. PubMed ID: 3185065
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monoclonal antibodies in the radionuclide diagnosis and therapy of tumors].
    Anokhin IuN; Dedenkov AN; Norets TA
    Med Radiol (Mosk); 1985 Jun; 30(6):72-8. PubMed ID: 3894856
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunoreactivity of radiolabeled antibodies--its impact on tumor targeting and strategies for preservation.
    Reilly R
    Cancer Biother Radiopharm; 2004 Dec; 19(6):669-72. PubMed ID: 15665615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.